The state of the visual sensory system in multiple sclerosis

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents a review of publications on the changes in the visual field analyzer in multiple sclerosis.

Full Text

Restricted Access

About the authors

Elvira I. Saidasheva

North-Western State Medical University named after I.I. Mechnikov; Children’s city multidisciplinary clinical specialized center for high medical technologies

Author for correspondence.
Email: esaidasheva@mail.ru
ORCID iD: 0000-0003-4012-7324

Dr of Med. Sci, Professor

Russian Federation, 191015, Saint Petersburg; 198205, Saint Petersburg

Ernest V. Boiko

North-Western State Medical University named after I.I. Mechnikov

Email: esaidasheva@mail.ru
ORCID iD: 0000-0002-7413-7478

Dr of Med. Sci, Professor

Russian Federation, 191015, Saint Petersburg

Svetlana V. Buyanovskaya

2 Children’s city multidisciplinary clinical specialized center for high medical technologies

Email: esaidasheva@mail.ru
ORCID iD: 0000-0001-7503-2611

MD, PhD

Russian Federation, 198205, Saint Petersburg

References

  1. Skoromets AA, Skoromets AP, Skoromets TA. Nervous diseases. [Nervnye bolezni]. Moscow: MED press-inform; 2005. (in Russ.)
  2. Nikiforov AS, Guseva MR. Neuroophthalmology. [Neirooftal’mologiya]. Moscow: GEOTAR-Media; 2008. (in Russ.)
  3. Mumentaler M, Matle Kh. Demyelinating diseases. Neurology. [Demieliniziruyushchie zabolevaniya. Nevrologiya]. Ed by Levin OS Moscow: MED press-inform; 2011. (in Russ.)
  4. Boiko AN, Kukel’ TM, Lysenko MA, et al. Clinical epidemiology of multiple sclerosis in Moscow. Сlinical demo graphic characteristics in population of one region of Moscow. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2014; 114(2):10-5. (in Russ.)
  5. Guzeva VI, Chukhlovina ML. Multiple sclerosis. Diagnostics and treatment (age aspects). [Rasseyannyi skleroz. Diagnostika i lechenie (vozrastnye aspekty)]. St. Peterburg: Foliant; 2003. (in Russ.)
  6. Lobzin SV, Golovkin VI, Semenova LA, Fominceva MV. Associated multiple sclerosis. Vestnik SZGMU im. I.I. Mechnikova. 2014;6(2):120-123. (in Russ.)
  7. Dobson R, Giovannoni G. Multiple sclerosis - a review. Eur. J. Neurol. 2019;26(1):27-40. doi: 10.1111/ene.13819.
  8. Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr. Opin. Neurol. 2018;31(6):752-9. doi: 10.1097/WCO.0000000000000622.
  9. Yamout BI, Alroughani R. Multiple sclerosis. Semin. Neurol. 2018;38(2):212-25. doi: 10.1055/s-0038-1649502.
  10. Boiko AN, Bykova OV, Maslova OI, et al. Multiple sclerosis in children. Rossiiskaya pediatricheskaya oftal’mologiya. 2001;(1):26-30. (in Russ.)
  11. Guzeva VI, ed. Federal guide on pediatric neurology. [Federal’noe rukovodstvo po detskoi nevrologii]. Moscow: MK; 2016. (in Russ.)
  12. Guseva MR, Boiko SYu, Boiko AN. The prognostic and immunogenetic features of optic neuritis in the children presenting with disseminated sclerosis. Russian Pediatric Ophthalmology. 2012;(1):10-4. (in Russ.)
  13. Voloshina NP, Egorkin OV, Evtushenko SK, Moskalenko MA. Proekt protokola lecheniya pediatricheskogo rasseyannogo skleroza. Mezhdunarodnyy nevrologicheskiy zhurnal. 2012;54(8):143-74. (in Russ.)
  14. Ghezzi A, Banwell B, Boyko A, Amato MP. The management of multiple sclerosis in children: European view. Mult. Scler. 2010;16(10):1258-67. doi: 10.1177/1352458510375568.
  15. Tenembaum SN. Treatment of multiple sclerosis and neuromyelitis optica in children and adults. Clin. Neurol. Neurosurg. 2013;115(1):21-9. doi: 10.1016/j.clineuro.2013.09.016.
  16. Yeshokumar AK, Narula S, Banwell B. Pediatric multiple sclerosis. Curr. Opin. Neurol. 2017;30(3):216-21. doi: 10.1097/WCO.0000000000000452.
  17. Kovalenko AV, Boiko EV, Bisaga BN, et al. Changes in the visual analyzer in multiple sclerosis. [Izmeneniya zritel’nogo analizatora pri rasseyannom skleroze]. St. Petersburg: VMedA; 2014. (in Russ.)
  18. Khaibullin TI, Khabirov FA, Devlikamova FI, Babicheva NN. Pathogenetic heterogenity of multiple sclerosis: key for understanding of the disease clinical polymorphism and individualized therapy developing. Nevrologicheskii vestnik. 2010;42(1):54-65. (in Russ.)
  19. Barabanova MA, Ivanova EM, Stoyanova OV, et al. Neurological findings in multiple sclerosis. Kubanskii nauchnyi meditsinskii vestnik. 2012;134(5):107-10. (in Russ.)
  20. Howard J, Trevick S, Younger DS. Epidemiology of multiple sclerosis. Neurol. Clin. 2016;34(4):919-39. doi: 10.1016/j.ncl.2016.06.016.
  21. Shmidt TE. Differential diagnosis of optic neuritis (review). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2012;112(9): 5-9. (in Russ.)
  22. Pula JH. Reder AT. Multiple sclerosis. Part I: neuro-ophthalmic manifestations. Curr. Opin. Ophthalmol. 2009;20(6):467-75. doi: 10.1097/ICU.0b013e328331913b.
  23. Beisse C. Eye and multiple sclerosis. Ophthalmologe. 2014;111(8):708. doi: 10.1007/s00347-013-2982-z.
  24. Rostasy K, Reindl M. Role of autoantibodies in acquired inflammatory demyelinating diseases of the central nervous system in children. Neuropediatrics. 2013;44(6):297-301. doi: 10.1055/s-0033-1358602.
  25. Pohl D, Krone B, Rostasy K, et al. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. J. Neurol. 2006;67(11):2063-5. doi: 10.1212/01.wnl.0000247665.94088.8d.
  26. Smirnov IE, Kucherenko AL, Shatilova NN, Kuzenkova LM. Diagnostic and pathogenetic significance of markers apoptosis in disseminated sclerosis in children. Pediatria. 2013;92(6):47-53. (in Russ.)
  27. Caprariello AV, Mangla S, Miller RH, Selkirk SM. Apoptosis of oligodendrocytes in the central nervous results in rapid focal demyelination. Ann. Neurol. 2012;72(3):395-405. doi: 10.1002/ana.23606.
  28. Rascol A, Clanet M. Multiple sclerosis from Charcot and Vulpian to the present time. Rev. Neurol. (Paris). 1982; 138(12):921-30. (in French)
  29. Scholl GB, Song HS, Wray SH. Uhthoffs symptom in optic neuritis: relationship to magnetic resonance imaging and development of multiple sclerosis. Ann. Neurol. 1991;30(2):180-4. doi: 10.1002/ana.410300209.
  30. Ignatova YuN, Smagina IV, Gridina AO, et al. Neuritis retrobulbaris of multiple sclerosis patients. Byulleten’ sibirskoi meditsiny. 2009;3(2):115-7. (in Russ.) doi: 10.20538/1682-0363-2009-3(2)-115-117.
  31. Neroev VV, Zueva MV, Tsapenko IV, et al. Neurodegenerative retinal alterations in relapsing-remitting multiple sclerosis and retrobulbar neuritis: structural and functional parallels. Rossiiskii oftal’mologicheskii zhurnal. 2012;5(4):63-8. (in Russ.)
  32. Nugumanova AM, Khamitova GKh. Features of optic neuritis as a symptom of multiple sclerosis (medical case). Prakticheskaya meditsina. 2013;70(1):99-100. (in Russ.)
  33. Zolnikova IV, Chudin AV, Egorova IV. Multifocal visual evoked potentials in clinical diagnostics. Rossiiskii oftal’mologicheskii zhurnal. 2013;6(3):99-105. (in Russ.)
  34. Laron M, Cheng H, Zhang B, et al.Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients. Mult. Scler. 2010;16(4):412-26. doi: 10.1177/1352458509359782.
  35. Narayanan D, Cheng H, Tang RA, Frishman LJ. Multifocal visual evoked potentials and contrast sensitivity correlate with ganglion cell-inner plexiform layer thickness in multiple sclerosis. Clin. Neurophysiol. 2019;130(1):180-8. doi: 10.1016/j.clinph.2018.10.007.
  36. Till C, Ghassemi R, Aubert-Broche B, et al. MRI correlates of cognitive impairment in childhood-onset multiple sclerosis. Neuropsychology. 2011;25(3):319-32. doi: 10.1037/a0022051.
  37. Kachan T, Marchanka L, Fedulov A, Dalidovich A. Diagnosis of optic neuropathy in patients with multiple sclerosis by means of scanning laser polarimetry and optical coherence tomography. Oftal’mologiya. Vostochnaya Evropa. 2015;24(1):51-8. (in Russ.)
  38. Hanson JV, Lukas SC, Pless M, Schippling S. Optical coherence tomography in multiple sclerosis. Semin. Neurol. 2016;36(2):177-84. Doi: 10,1055/с-0036-1582226.
  39. Britze J, Frederiksen JL. Optical coherence tomography in multiple sclerosis. Eye (Lond.). 2018;32(5):884-8. doi: 10.1038/s41433-017-0010.
  40. Höh AE, Beisse C. Oculomotor system and multiple sclerosis. Ophthalmologe. 2014;111(8):727-32. (in German) doi: 10.1007/s00347-013-2985-9.
  41. Surakka J, Ruutiainen J, Romberg A, et al. Pupillary function in early multiple sclerosis. Clin. Auton. Res. 2008;18(3):150-4. doi: 10.1007/s10286-008-0471-2.
  42. Rodez Benavent SA, Nygaard GO, Harbo HF, et al. Fatigue and cognition: pupillary responses to problem-solving in early multiple sclerosis patients. Brain Behav. 2017;7(7):e00717. doi: 10.1002/brb3.717.
  43. Kuchina NV, Yakushina TI, Kotov SV. Assessment of color vision for diagnosis and dynamic monitoring of multiple sclerosis. Al’manakh klinicheskoi meditsiny. 2015;(36):47-52.(in Russ.) doi: 10.18786/2072-0505-2015-36-47-52.
  44. Yuksel B, Dogan B, Koctekin B, et al. Color vision testing versus pattern visual evoked potentials and optical coherence tomography parameters in subclinical optic nerve involvement in multiple sclerosis. J. Clin. Neurosci. 2019;61:48-53. doi: 10.1016/j.jocn.2018.11.011.
  45. Anssari N, Vosoughi R, Mullen K, Mansouri B. Selective colour vision deficits in multiple sclerosis at different temporal stages. Neuroophthalmology. 2019;44(1):16-23. doi: 10.1080/01658107.2019.1615960.
  46. Lampert EJ, Andorra M, Torres-Torres R, et al. Color vision impairment in multiple sclerosis points to retinal ganglion cell damage. J. Neurol. 2015;262(11):2491-7. doi: 10.1007/s00415-015-7876-3.
  47. Rothman A, Murphy OC, Fitzgerald KC, et al. Retinal measurements predict 10-year disability in multiple sclerosis. Ann. Clin. Transl. Neurol. 2019;6(2):222-32. doi: 10.1002/acn3.674.
  48. Green AJ, McQuaid S, Hauser SL, et al. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain. 2010;133(Pt 6):1591-601. doi: 10.1093/brain/awq080.
  49. Balk LJ, Coric D, Nij Bijvank JA, et al. Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis. Mult. Scler. 2018;24(6):767-76. doi: 10.1177/1352458517708463.
  50. Grecescu MJ. Optical coherence tomography versus visual evoked potentials in detecting subclinical visual impairment in multiple sclerosis. J. Med. Life. 2014;7(4):538-41.
  51. Saidha S, Syc SB, Durbin MK, et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult. Scler. 2011;17(12):1449-63. doi: 10.1177/1352458511418630.
  52. Saidha S, Syc SB, Ibrahim MA, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain. 2011;134(2):518-33. doi: 10.1093/brain/awq346.
  53. Kolbe S, Chapman C, Nguyen T, et al. Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis. Neuroimage. 2009;45(3):679-86. doi: 10.1016/j.neuroimage.2008.12.047.
  54. Klistorner A, Chaganti J, Garrick R, et al. Magnetisation transfer ratio in optic neuritis is associated with axonal loss, but not with demyelination. Neuroimage. 2011;56(1):21-6. doi: 10.1016/j.neuroimage.2011.02.041.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86503 от 11.12.2023 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80630 от 15.03.2021 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies